echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > In 2022, there will be frequent personnel changes in pharmaceutical companies, with more than 250 senior executives leaving

    In 2022, there will be frequent personnel changes in pharmaceutical companies, with more than 250 senior executives leaving

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The "big change" of management is a microcosm
    of the frequent changes in senior management in the pharmaceutical industry.
    According to incomplete statistics, more than 250 executives in the pharmaceutical industry have announced their departures in 2022, and an average of 1 pharmaceutical company executive will leave
    every day.
    Among them, there are many executives from multinational pharmaceutical companies in Greater China, managers of traditional pharmaceutical companies, and R&D leaders and founders of biopharmaceutical companies
    .

     
    For example, on December 16, Henan Tailong Pharmaceutical Co.
    , Ltd.
    issued an announcement announcing the resignation
    of Vice Chairman Li Hui.
    According to the announcement, the company recently received a written resignation report
    from Mr.
    Li Hui, vice chairman and director of the company.
    Due to his health, Mr.
    Li Hui applied to resign as the vice chairman, director and member of the strategic decision-making committee of the ninth board of directors of the company, and at the same time resigned from the relevant positions of its subsidiaries, and will no longer hold any position
    in the company after his resignation.

     
    On December 10, Dongea Ejiao Co.
    , Ltd.
    suddenly issued an announcement that the board of directors recently received a written resignation report submitted by Mr.
    Liu Yanfeng and Mr.
    Ren Ruzhuo, vice presidents, and due to job changes, Mr.
    Liu Yanfeng and Mr.
    Ren Ruzhuo applied to resign as vice
    presidents of the company.

     
    In addition, in the last month, a number of pharmaceutical directors have also resigned
    .
    Among them, Zhangzhou Pian Zixi Pharmaceutical Co.
    , Ltd.
    issued an announcement on December 15 that Mr.
    Chen Zhiyan resigned from the board of directors and other positions to the board of directors due to work adjustment, and after his resignation, Mr.
    Chen Zhiyan no longer held any position
    in the company.

     
    Prior to this, Wisdom Pharma also announced on December 14 that the company's board of directors recently received a written resignation report from Mr.
    Zhang Jiguo, an independent director of the company, and Mr
    .
    Zhang Jiguo applied to resign as an independent director, a member of the strategy committee of the board of directors and a member of the remuneration and assessment committee of the fifth board of directors of the company due to personal reasons.
    After his resignation, Mr.
    Zhang Jiguo will no longer hold any position
    in the Company.

     
    The departure of senior executives of pharmaceutical companies is usually accompanied by the reform and transformation of pharmaceutical companies and structural adjustments
    .
    In recent years, driven by centralized procurement, traditional generic drug companies have begun to transform to survive, so changing managers has become an important step
    for enterprises to launch transformation plans.
    In addition to domestic pharmaceutical companies, in fact, many multinational pharmaceutical companies have also experienced a change of coach
    .

     
    It is worth noting that from the statistical point of view, pharmaceutical executives also left as frequently
    as they left last year.
    According to publicly available statistics alone, there will be more than 200 senior executives of pharmaceutical companies in 2022
    .
    Industry insiders believe that talent is the source of enterprise innovation and the core element
    of enterprise development.
    Under the background of the current complex pharmaceutical environment and the intensifying competition of innovative drugs, the talent changes of pharmaceutical companies will become more frequent in the future, and talents with professional capabilities that match the current development of enterprises will be more and more popular
    with enterprises.

     
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.